New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Pharming Group N.V.
PHGUF
Shape
US Flag

PNK

Unprofitable

Unprofitable

558M

Biotechnology

Next Earning date - 24 Oct 2024

558M

Biotechnology

Next Earning date - 24 Oct 2024

0.82USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

15%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

36%

Quote Panel

Shape
Updated October 24, 2024
1W 0.00 % 1M 9.01 % 3M -2.95 % 1Y -27.81 %

Key Metrics

Shape
  • Market Cap

    558.29M


  • Shares Outstanding

    678.35M


  • Share in Float

    666.59M


  • Dividende

    0


  • Earning Date

    24 Oct 2024


  • Price Target

    0.823


  • Average Volume

    884


  • Beta

    0.843


  • Range

    0.75-1.29


  • Industry

    Biotechnology


  • Website

    https://www.pharming.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.00x

P/S Ratio

2.66x

P/B Ratio

0.5

Debt/Equity

-4.6%

Net Margin

$-0.0

EPS

How PHGUF compares to sector?

P/E Ratio

Relative Strength

Shape

PHGUF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$313M

Shape325%

2025-Revenue

$0.01

Shape-274%

2025-EPS

$75M

Shape1861%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+1638%

0.01
vs -0.00

Q4.22

arrow
arrow

N/A

-0.02
vs 0

Q1.23

arrow
arrow

N/A

-0.02
vs 0.01

Q2.23

arrow
arrow

-90%

0
vs 0.02

Q3.23

arrow
arrow

N/A

0.01
vs 0.01

Q4.23

arrow
arrow

N/A

-0.00
vs -0.02

Q1.24

arrow
arrow

N/A

-0.02
vs -0.02

Q2.24

arrow
arrow

N/A

-0.00
vs 0

Q3.24

arrow
arrow

N/A

-0.00
vs 0.01

Q4.24

arrow
arrow

+115%

0
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+4%

54.2M  vs 51.9M

Q4.22

arrow
arrow

+4%

54.6M  vs 52.5M

Q1.23

arrow
arrow

-9%

42.5M  vs 46.6M

Q2.23

arrow
arrow

+9%

54.9M  vs 50.1M

Q3.23

arrow
arrow

+23%

66.7M  vs 54.2M

Q4.23

arrow
arrow

+53%

83.3M  vs 54.6M

Q1.24

arrow
arrow

+30%

55.3M  vs 42.5M

Q2.24

arrow
arrow

+34%

73.7M  vs 54.9M

Q3.24

arrow
arrow

+15%

76.9M  vs 66.7M

Q4.24

arrow
arrow

+1%

83.8M  vs 83.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.08

Q4.22

arrow
arrow

-7%

-0.07
vs 0.05

Q1.23

arrow
arrow

-6%

-0.06
vs -0.07

Q2.23

arrow
arrow

+1%

0.01
vs -0.06

Q3.23

arrow
arrow

+2%

0.02
vs 0.01

Q4.23

arrow
arrow

-1%

-0.01
vs 0.02

Q1.24

arrow
arrow

-6%

-0.06
vs -0.01

Q2.24

arrow
arrow

-1%

-0.01
vs -0.06

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News